- Home
- OCX vs ENZ Comparison
OCX vs ENZ Comparison
Compare OCX & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCX
- ENZ
- Stock Information
- Founded
- OCX 2009
- ENZ 1976
- Country
- OCX United States
- ENZ United States
- Employees
- OCX N/A
- ENZ N/A
- Industry
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ENZ Medical Specialities
- Sector
- OCX Health Care
- ENZ Health Care
- Exchange
- OCX Nasdaq
- ENZ Nasdaq
- Market Cap
- OCX 80.1M
- ENZ 34.2M
- IPO Year
- OCX N/A
- ENZ N/A
- Fundamental
- Price
- OCX $3.87
- ENZ $0.46
- Analyst Decision
- OCX Buy
- ENZ
- Analyst Count
- OCX 3
- ENZ 0
- Target Price
- OCX $4.42
- ENZ N/A
- AVG Volume (30 Days)
- OCX 120.1K
- ENZ 130.5K
- Earning Date
- OCX 04-11-2025
- ENZ 03-25-2025
- Dividend Yield
- OCX N/A
- ENZ 20.90%
- EPS Growth
- OCX N/A
- ENZ N/A
- EPS
- OCX N/A
- ENZ N/A
- Revenue
- OCX $709,000.00
- ENZ $30,314,000.00
- Revenue This Year
- OCX N/A
- ENZ N/A
- Revenue Next Year
- OCX $106.34
- ENZ N/A
- P/E Ratio
- OCX N/A
- ENZ N/A
- Revenue Growth
- OCX N/A
- ENZ N/A
- 52 Week Low
- OCX $1.92
- ENZ $0.41
- 52 Week High
- OCX $4.75
- ENZ $1.32
- Technical
- Relative Strength Index (RSI)
- OCX 71.87
- ENZ 33.92
- Support Level
- OCX $3.60
- ENZ $0.46
- Resistance Level
- OCX $4.75
- ENZ $0.53
- Average True Range (ATR)
- OCX 0.47
- ENZ 0.04
- MACD
- OCX 0.10
- ENZ 0.00
- Stochastic Oscillator
- OCX 63.77
- ENZ 23.33
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.